ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 101 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $611,000 | -7.3% | 41,994 | +14.7% | 0.00% | – |
| Q3 2021 | $659,000 | -92.2% | 36,600 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $8,421,000 | -64.9% | 3,845,423 | -4.0% | 0.00% | -69.2% |
| Q1 2019 | $23,989,000 | -18.6% | 4,004,814 | +0.5% | 0.01% | -27.8% |
| Q4 2018 | $29,459,000 | -30.0% | 3,986,422 | +37.5% | 0.02% | -14.3% |
| Q3 2018 | $42,084,000 | -29.1% | 2,898,310 | -2.4% | 0.02% | -30.0% |
| Q2 2018 | $59,321,000 | +31.5% | 2,970,465 | +15.3% | 0.03% | +30.4% |
| Q1 2018 | $45,121,000 | -29.5% | 2,575,391 | -0.8% | 0.02% | -25.8% |
| Q4 2017 | $64,037,000 | +22.2% | 2,596,814 | +27.9% | 0.03% | +19.2% |
| Q3 2017 | $52,417,000 | -1.2% | 2,030,869 | +3.9% | 0.03% | 0.0% |
| Q2 2017 | $53,030,000 | +41.3% | 1,955,381 | +55.4% | 0.03% | +36.8% |
| Q1 2017 | $37,522,000 | -9.5% | 1,258,277 | -17.6% | 0.02% | -9.5% |
| Q4 2016 | $41,457,000 | +3.3% | 1,527,549 | -2.5% | 0.02% | 0.0% |
| Q3 2016 | $40,144,000 | +38.0% | 1,567,513 | -0.5% | 0.02% | +31.2% |
| Q2 2016 | $29,088,000 | -6.4% | 1,574,884 | -3.9% | 0.02% | 0.0% |
| Q1 2016 | $31,067,000 | -30.3% | 1,639,454 | -0.9% | 0.02% | -30.4% |
| Q4 2015 | $44,583,000 | – | 1,654,894 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |